St18 - suppression of tumorigenicity 18

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in several processes, including cytokine-mediated signaling pathway; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; and regulation of transcription by RNA polymerase II. Predicted to be part of protein-DNA complex. Predicted to be active in nucleus. Is expressed in several structures, including central nervous system; eye; foregut-midgut junction; future brain; and olfactory epithelium. Orthologous to human ST18 (ST18 C2H2C-type zinc finger transcription factor). [provided by Alliance of Genome Resources, Apr 2022]